Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 4NETWORK 4NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 9Genitourinary 7Gynecologic 4Gastrointestinal 4Dermatologic 3Sarcoma 2Other hematologic neoplasm 2Lymphoid 2CNS 2Thoracic 1Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 71Carboplatin 68Paclitaxel 57Radiotherapy 43Specimen Handling 37Gemcitabine 36Erlotinib Hydrochloride 32Etoposide 30Magnetic Resonance Spectroscopy 29Docetaxel 28Taxes 27Pemetrexed 23Platinum 20Vinorelbine 191,2-diaminocyclohexaneplatinum II citrate 19Bevacizumab 18Cyclophosphamide 16Biopsy 16Radiation 15pembrolizumab 14Immunoglobulin G 12Disulfides 12Topotecan 11Gefitinib 11durvalumab 9atezolizumab 9aldesleukin 9Nivolumab 9Irinotecan 9Bortezomib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Amplified Fragment Length Polymorphism Analysis × Thoracic × Clear all
NCT00693836 2013-08-12

Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region

National Cancer Institute (NCI)

Unknown
2,000 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡